TY - JOUR AU - Raman, Subha V. AU - Hor, Kan N. AU - Mazur, Wojciech AU - He, Xin AU - Kissel, John T. AU - Smart, Suzanne AU - McCarthy, Beth AU - Roble, Sharon L. AU - Cripe, Linda H. PY - 2017 DA - 2017/02/20 TI - Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial JO - Orphanet Journal of Rare Diseases SP - 39 VL - 12 IS - 1 AB - Cardiomyopathy is a leading cause of morbidity and mortality in boys with Duchenne muscular dystrophy (DMD). We recently showed in a 12-month double-blind randomized controlled trial that adding eplerenone to background medical therapy was cardioprotective in this population. The objective of this study was to evaluate the safety and efficacy of longer-term eplerenone therapy in boys with DMD. SN - 1750-1172 UR - https://doi.org/10.1186/s13023-017-0590-8 DO - 10.1186/s13023-017-0590-8 ID - Raman2017 ER -